These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34109728)

  • 1. Otilonium Bromide treatment prevents nitrergic functional and morphological changes caused by chronic stress in the distal colon of a rat IBS model.
    Traini C; Idrizaj E; Garella R; Faussone-Pellegrini MS; Baccari MC; Vannucchi MG
    J Cell Mol Med; 2021 Jul; 25(14):6988-7000. PubMed ID: 34109728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Otilonium Bromide Prevents Cholinergic Changes in the Distal Colon Induced by Chronic Water Avoidance Stress, a Rat Model of Irritable Bowel Syndrome.
    Traini C; Idrizaj E; Biagioni C; Baccari MC; Vannucchi MG
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated otilonium bromide administration prevents neurotransmitter changes in colon of rats underwent to wrap restraint stress.
    Traini C; Evangelista S; Girod V; Faussone-Pellegrini MS; Vannucchi MG
    J Cell Mol Med; 2017 Apr; 21(4):735-745. PubMed ID: 27866394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in nitrergic and tachykininergic pathways in rat proximal colon in response to chronic treatment with otilonium bromide.
    Cipriani G; Gibbons SJ; Saravanaperumal SA; Malysz J; Sha L; Szurszewski JH; Linden DR; Evangelista S; Faussone-Pellegrini MS; Vannucchi MG; Farrugia G
    Neurogastroenterol Motil; 2015 Jul; 27(7):997-1009. PubMed ID: 25930994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nitrergic system on colonic motility in a rat model of irritable bowel syndrome.
    Temiz TK; Demir O; Simsek F; Kaplan YC; Bahceci S; Karadas B; Celik A; Koyluoglu G
    Indian J Pharmacol; 2016; 48(4):424-429. PubMed ID: 27756955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction.
    Vicario M; Alonso C; Guilarte M; Serra J; Martínez C; González-Castro AM; Lobo B; Antolín M; Andreu AL; García-Arumí E; Casellas M; Saperas E; Malagelada JR; Azpiroz F; Santos J
    Psychoneuroendocrinology; 2012 Jan; 37(1):65-77. PubMed ID: 21641728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of excitatory and inhibitory neurotransmitters in the colon of rats underwent to the wrap partial restraint stress.
    Traini C; Evangelista S; Girod V; Faussone-Pellegrini MS; Vannucchi MG
    Neurogastroenterol Motil; 2016 Aug; 28(8):1172-85. PubMed ID: 26972279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide.
    Paragomi P; Rahimian R; Kazemi MH; Gharedaghi MH; Khalifeh-Soltani A; Azary S; Javidan AN; Moradi K; Sakuma S; Dehpour AR
    Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):118-26. PubMed ID: 24471407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
    Martinez V; Taché Y
    Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of baldrinal of Valeriana jatamansi on expression of CRF, TPH1 mRNA and 5-HT in rats with irritable bowel syndrome].
    Tao SY; Xiao CR; Wang J; Zhang SJ; Gao YS; Mu FY; Wang YC; Yan XL
    Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(2):347-351. PubMed ID: 28948742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of patchouli alcohol on stress-induced diarrhea-predominant irritable bowel syndrome.
    Zhou TR; Huang JJ; Huang ZT; Cao HY; Tan B
    World J Gastroenterol; 2018 Feb; 24(6):693-705. PubMed ID: 29456408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritable bowel syndrome: focus on otilonium bromide.
    Boeckxstaens G; Clavé P; Corazziari ES; Tack J
    Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):131-7. PubMed ID: 24417261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Eur J Pharmacol; 2019 Jun; 852():198-206. PubMed ID: 30935894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.
    Buckley MM; O'Halloran KD; Rae MG; Dinan TG; O'Malley D
    J Physiol; 2014 Dec; 592(23):5235-50. PubMed ID: 25260633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion.
    O'Malley D; Cryan JF; Dinan TG
    Brain Behav Immun; 2013 May; 30():115-24. PubMed ID: 23369733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.
    Forte E; Pizzoferrato M; Lopetuso L; Scaldaferri F
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):25-37. PubMed ID: 22338545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.
    Chmielewska-Wilkoń D; Reggiardo G; Egan CG
    World J Gastroenterol; 2014 Sep; 20(34):12283-91. PubMed ID: 25232263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IBS and the role of otilonium bromide.
    Boeckxstaens G; Corazziari ES; Mearin F; Tack J
    Int J Colorectal Dis; 2013 Mar; 28(3):295-304. PubMed ID: 23178991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.